Randomized, Placebo-controlled Trial of an AMPAkine in Major Depressive Disorder
Status:
Withdrawn
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test a candidate drug, Org 24448,in a phase II clinical trial
in adult patients with moderately treatment-resistant unipolar major depressive disorder.